ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHA:600479)

SHA:600479 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	3,729	3,629	3,630	3,798	4,026	3,664
Revenue Growth	5.84%	-0.03%	-4.44%	-5.66%	9.89%	1.02%
Gross Profit Gross Profit Growth	1,812	1,765	1,679	1,748	1,731	1,626
Operating Income Operating Income Growth	411.35	367.18	288.57	376.42	404.85	354.6
Net Income Net Income Growth	339.41	286.29	230.76	320.41	302.51	302.06
Earnings Per Share EPS Growth	0.73	0.66	0.56	0.76	0.71	0.72
EPS Growth	25.46%	19.13%	-26.43%	7.32%	-2.11%	1.69%

Revenue by Segment

Chart

Fiscal Year	FY 2025
Period Ending	Dec 31, 2025
Others Others Growth	222.13
Production of Chinese Medicinal Materials and Decoction Pieces Production of Chinese Medicinal Materials and Decoction Pieces Growth	148.81
Wholesale and Retail of Pharmaceutical Products Wholesale and Retail of Pharmaceutical Products Growth	1,552
Offset of Business Segment Offset of Business Segment Growth	-293.12
Drug Production Drug Production Growth	1,999
Total Total Growth	3,629

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	707.98	782.08	1,349	1,998	1,914	1,422
Total Debt Total Debt Growth	156.01	101.54	58.64	116.71	124.24	148.93
Net Cash (Debt) Net Cash Growth	551.97	680.55	1,291	1,881	1,789	1,273
Net Cash Growth	-30.98%	-47.27%	-31.39%	5.13%	40.60%	-5.93%
Net Cash Per Share Net Cash Per Share Growth	1.19	1.58	3.12	4.45	4.18	3.04

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	577.78	480.24	398.77	443.12	733.47	485.57
Capital Expenditures CapEx Growth	-120.31	-124.17	-47.32	-43.99	-34.43	-71.88
Free Cash Flow Free Cash Flow Growth	457.47	356.08	351.45	399.13	699.04	413.69
Free Cash Flow Growth	25.72%	1.32%	-11.95%	-42.90%	68.97%	-7.06%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	48.60%	48.65%	46.25%	46.02%	42.98%	44.38%
Operating Margin	11.03%	10.12%	7.95%	9.91%	10.05%	9.68%
Pretax Margin	12.69%	11.99%	9.24%	12.12%	11.07%	11.83%
Profit Margin	9.10%	7.89%	6.36%	8.43%	7.51%	8.24%
FCF Margin	12.27%	9.81%	9.68%	10.51%	17.36%	11.29%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.360	0.380	0.360	0.350	0.350	0.600
Dividend Per Share Growth	0%	5.56%	2.86%	0%	-41.67%	-40.00%
Dividend Yield	3.31%	3.74%	3.37%	3.25%	3.63%	4.78%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	14.87	17.47	19.62	14.42	13.64	17.39
Forward PE	-	13.60	13.60	13.60	13.60	13.60
P/FCF Ratio	11.68	14.04	12.89	11.57	5.90	12.70
PS Ratio	1.43	1.38	1.25	1.22	1.02	1.43

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error